Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling.
Steelman LS, Chappell WH, Akula SM, Abrams SL, Cocco L, Manzoli L, Ratti S, Martelli AM, Montalto G, Cervello M, Libra M, Candido S, McCubrey JA.
Steelman LS, et al. Among authors: mccubrey ja.
Adv Biol Regul. 2020 Dec;78:100758. doi: 10.1016/j.jbior.2020.100758. Epub 2020 Sep 28.
Adv Biol Regul. 2020.
PMID: 33022466
Review.